On May 28, 2025, Spruce Biosciences, Inc. sold one share of its newly designated Series A Preferred Stock for $100 to Executive Chair Michael Grey, which will influence future voting on Reverse Stock Split proposals. Shareholders must approve certain measures in future meetings, with a record date set for May 30, 2025 for the upcoming annual meeting scheduled on July 22, 2025.